ahlam1399
09-11-2015, 11:42 PM
UPDATE 1-**vartis heart failure drug should have 17 pct discount -analysis
Sept 11 (Reuters) - A new **vartis AG drug to treat heart failure should cost 17 percent less than its list price of $4,560 per year to keep health costs in line with growth in the overall U.S. eco**my, according to the **nprofit ICER.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49c65d47/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=c_5kTDW8x4c:hP4UQKa4X18:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=c_5kTDW8x4c:hP4UQKa4X18:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/c_5kTDW8x4c
Sept 11 (Reuters) - A new **vartis AG drug to treat heart failure should cost 17 percent less than its list price of $4,560 per year to keep health costs in line with growth in the overall U.S. eco**my, according to the **nprofit ICER.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49c65d47/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=c_5kTDW8x4c:hP4UQKa4X18:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=c_5kTDW8x4c:hP4UQKa4X18:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=c_5kTDW8x4c:hP4UQKa4X18:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/c_5kTDW8x4c